Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Biomedical Engineering

Background:

• The effectiveness of drug-eluting stents (DES) in preventing restenosis varies among patient groups.
• Identifying factors that predict restenosis is crucial for optimizing percutaneous coronary interventions (PCI).

Purpose of the Study:

• To identify key predictors of restenosis and target lesion revascularization (TLR) following DES implantation.
• To compare the efficacy of sirolimus-eluting stents (SES) versus paclitaxel-eluting stents (PES) in predicting restenosis.

Main Methods:

• Prospective data collection from 1845 patients who received SES or PES for de novo lesions between August 2002 and December 2004.
• Angiographic restenosis defined as diameter stenosis ≥50% and TLR as any revascularization procedure.
• Multivariable analysis to determine the strongest predictors of restenosis and TLR.

Main Results:

• Vessel size, final diameter stenosis, and stent type were significant predictors of restenosis.
• Smaller vessel size (0.5 mm decrease) increased odds of restenosis (OR 1.74) and TLR (OR 1.65).
• Increased final diameter stenosis (5%) raised odds of restenosis (OR 1.30) and TLR (OR 1.18).
• SES demonstrated lower odds of restenosis (OR 0.60) and TLR (OR 0.67) compared to PES.

Conclusions:

• Vessel size and drug-eluting stent type are critical predictors of both angiographic and clinical restenosis.
• Drug-eluting stent type significantly impacts restenosis rates, particularly in smaller coronary arteries.